|
HIPK3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.73039999948632E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.20550000004549E-06 |
| Normal-vs-Stage2 |
7.09050000047284E-07 |
| Normal-vs-Stage3 |
3.30720000052409E-07 |
| Normal-vs-Stage4 |
8.36909999968327E-07 |
| Stage1-vs-Stage2 |
4.431800E-01 |
| Stage1-vs-Stage3 |
2.360400E-01 |
| Stage1-vs-Stage4 |
3.517200E-01 |
| Stage2-vs-Stage3 |
8.832400E-01 |
| Stage2-vs-Stage4 |
8.944400E-01 |
| Stage3-vs-Stage4 |
9.960200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.51720000019351E-07 |
| Normal-vs-AfricanAmerican |
3.520000E-03 |
| Normal-vs-Asian |
1.10769999994709E-06 |
| Caucasian-vs-AfricanAmerican |
1.397010E-01 |
| Caucasian-vs-Asian |
7.069200E-01 |
| AfricanAmerican-vs-Asian |
1.467380E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.99819999990858E-07 |
| Normal-vs-Female |
8.28260000029779E-07 |
| Male-vs-Female |
2.328400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.91950000000474E-06 |
| Normal-vs-Age(41-60Yrs) |
5.37689999968727E-07 |
| Normal-vs-Age(61-80Yrs) |
1.02729999951201E-07 |
| Normal-vs-Age(81-100Yrs) |
1.228330E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.327000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.210500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.109000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.332200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.311200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.349000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.391610E-02 |
| Classical-VS-Follicular |
1.000240E-02 |
| Classical-VS-Other |
2.213000E-01 |
| Classical-VS-Normal |
3.91809999999992E-06 |
| Tall-VS-Follicular |
7.753400E-01 |
| Tall-VS-Other |
6.428200E-01 |
| Tall-VS-Normal |
8.78350000510508E-08 |
| Follicular-VS-Other |
5.895800E-01 |
| Follicular-VS-Normal |
9.61430000057106E-08 |
| Other-VS-Normal |
5.71459999999524E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.2580999997347E-07 |
| Normal-vs-N1 |
1.388450E-04 |
| N0-vs-N1 |
3.370000E-01 |
|
|
